How pathogenic CD4 T cells in Rheumatoid Arthritis (RA) develop remains poorly understood.
Significance Statement
How arthritis-causing T cells trigger rheumatoid arthritis (RA) is not understood since it is difficult to differentiate T cells activated by inflammation in arthritic joints from those activated through their TCR by self-antigens. We developed a model to identify and study antigen-specific T cell responses in arthritis. Nur77-a specific marker of TCR signaling-was used to identify antigenactivated CD4 T cells in the SKG arthritis model and patients with RA. Nur77 could distinguish highly arthritogenic and autoreactive T cells in SKG mice. The enhanced autoreactivity was associated with increased IL-6-receptor-signaling, likely contributing to their arthritogenicity.
These data highlight a functional correlate between Nur77 expression, arthritogenic T cell populations, and heightened IL-6 sensitivity in SKG mice with translatable implications for human RA.
Introduction
Rheumatoid arthritis (RA) is a chronic, destructive autoimmune disease that targets both joints and other organs. CD4 T cells have long been appreciated to play a crucial role in the pathogenesis of RA (1) (2) (3) (4) . Cellular and biochemical analyses of human CD4 T cells have revealed abnormal TCR signaling in RA patients (5) (6) (7) (8) . Surpisingly, CD4 T cells from patients with RA are hypo-responsive to TCR engagement ex vivo as evidenced by reduced calcium mobilization and IL-2 production (9, 10) . This may be due, in part, to reduced TCRz and LAT expression, and cellular changes associated with immune senescence (6, 7, (11) (12) (13) (14) (15) (16) ). Yet, despite this, CD4 T cells in RA hyper-proliferate during clonal expansion and differentiate into effector cells that drive disease (17, 18) . It is not currently understood how to reconcile these paradoxical observations of diminished TCR signaling in the setting of increased T cell proliferation and effector functions, nor is it clear whether this RA T cell phenotype is directly causal in disease pathogenesis or rather results from exposure to chronic inflammation. The inability to identify relevant arthritogenic T cells in patients and in murine disease models has limited our understanding of disease-initiating events in RA. In this report, we have developed a strategy to overcome this limitation by taking advantage of the dynamic expression pattern of Nur77(Nr4a1) in T cells.
Nr4a1 is an immediate early gene that encodes the orphan nuclear hormone receptor Nur77. It is rapidly and robustly upregulated by TCR but not cytokine stimulation (19, 20) .
Therefore, Nur77 expression in murine and human T cells serves as a specific marker of TCR signaling, but is insensitive to cytokine stimulation (21) (22) (23) (24) . Detection of Nur77 expression can be used to identify T cells stimulated by direct self-antigen exposure prior to disease initiation as well as in the context of complex immune responses and chronic autoimmune diseases in which inflammatory cytokines can influence T cell phenotypes. Indeed, gene expression data show that endogenous Nr4a1 transcripts are highly upregulated in autoantigen-specific CD4 T cells in vivo in the context of bona fide autoimmune disease (Immunological Genome Project; www.immgen.org, T.4.Pa.BDC) (25) . This suggested to us that Nur77 expression could be employed to identify autoantigen-specific CD4 T cells in RA.
SKG mice harbor a profoundly hypomorphic variant of the Zap70 cytoplasmic tyrosine kinase, a molecule that is critical for proximal TCR signal transduction. As a consequence, SKG mice exhibit impaired thymocyte negative selection, giving rise to T cells with a more potentially autoreactive TCR repertoire (26) . In response to either an innate immune stimulus in the form of zymosan injection or adoptive transfer of CD4 T cells into lymphopenic hosts, tolerance is broken, and mice develop an erosive inflammatory arthritis that resembles RA. For example, rheumatoid factor, anti-CCP antibodies and interstitial lung inflammation develop at the onset of disease (26) . The SKG mouse provides a useful model to study early events in RA pathogenesis; not only does it capture many important features of human RA, but SKG also offers two advantages over other RA models. First, unlike the more commonly used collageninduced arthritis (27) or K/BxN serum-transfer models of arthritis, which both bypass the initial break in TCR tolerance (28) , the SKG mice exhibit a loss in central, and likely peripheral, tolerance that can be molecularly dissected. Hence this model uniquely allows us to study arthritis-causing T cells both before and during disease. Second, it recapitulates the paradoxical ability of RA CD4 T cells to differentiate into pathogenic effector cells despite impaired TCR signaling (6, 7, (11) (12) (13) (14) (15) (16) (17) (18) 26) .
A recent study of the SKG model has identified one specific arthritogenic TCR directed against a ubiquitous self-antigen (29) , but it is not known whether rare antigen-specific T cell clones drive disease, or whether the entire pre-immune TCR repertoire has arthritogenic potential because it is highly autoreactive. Nor is it clear how tolerance of such clones is broken in the face of profoundly depressed TCR signaling in SKG mice. To address these questions we backcrossed the Nur77-eGFP BAC transgenic reporter line (in which eGFP protein expression is under the control of the Nr4a1 regulatory region (24) ) onto the SKG mouse model of arthritis.
The resulting so-called SKGNur mice provided us with a tool to facilitate identification and study of arthritogenic CD4 T cells both before and after disease initiation. Despite impaired TCR signal transduction, the peripheral naïve CD4 T cells from SKG mice expressed higher levels of Nur77-eGFP relative to those of wild type mice. This suggested that even before disease initiation, SKG mice harbor a profoundly autoreactive T cell repertoire that exhibits increased downstream signaling despite impaired Zap70 function. We show here that the amount of Nur77-eGFP expression in CD4 T cells from SKG mice correlated with both their autoreactivity and their arthritogenicity. We found that the SKGNur CD4 T cells that expressed the highest level of the Nur77-eGFP reporter (GFP hi ) differentiated more readily into IL-17 producing cells in vivo. While examining why GFP hi cells were pre-disposed to differentiate into Th17 effector T cells, we observed profoundly enhanced IL-6-dependent signaling in GFP hi CD4 T cells from SKG mice. Apparently, the autoimmune repertoire despite being coupled with impaired TCR signal transduction capacity in the SKG model resulted in reduced expression of suppressor of cytokine signaling 3 (SOCS3)-a key negative regulator of IL-6 signaling. Likewise, we found SOCS3 expression was downregulated in RA synovium. This in turn suggests that, despite impaired TCR signaling, autoreactive T cells exposed to chronic antigen stimulation exhibit heightened sensitivity to IL-6 receptor signaling which contributes to their arthritogenicity in SKG mice, and perhaps in patients with RA.
Results

A fluorescent reporter of TCR signaling reveals and marks self-reactivity of the CD4 T cell repertoire in SKG mice.
We sought to take advantage of a transcriptional reporter of Nr4a1 expression, Nur77-eGFP BAC Tg, in order to examine antigen-specific signaling in pathogenic SKG T cells. Since
Nur77 expression is induced downstream of TCR but not cytokine receptor signaling (21, 23, 24) , it can serve as a specific reporter of antigen-receptor signaling in T cells in vitro or in vivo (21) (22) (23) (24) . We back-crossed the Nur77-eGFP BAC Tg reporter (24) into either wild type (WT) or SKG mice, both on the Balb/c background (hereafter referred to as WTNur or SKGNur, respectively). We confirmed that the introduction of the Nur77-eGFP BAC Tg reporter into the SKG mouse model did not alter their phenotype. Indeed, the SKGNur CD4 T cells continued to demonstrate dramatic hyporesponsiveness to in vitro polyclonal TCR stimulation, consistent with published data (26, 30) , and developed a severe inflammatory and erosive arthritis after zymosan challenge ( Fig. S1A-C ).
It has previously been shown that thymic negative selection is quite impaired in SKG mice because TCR signaling is exceptionally dampened (26) . As a result, highly autoreactive T cells, that would ordinarily be deleted, are instead positively selected. Although one SKG autoreactive TCR has been cloned (29) , it remains unknown whether rare antigen-specific T cell clones drive disease, or whether the entire repertoire has arthritogenic potential because it is highly autoreactive. The Nur77-eGFP distribution in SKG mice is broad and overlaps with the distribution seen in normal mice (Fig. 1A-B) . Following stimulation with zymosan, which induces arthritis, there is an enrichment of Nur77-eGFP expressing CD4 T cells with higher levels of GFP in draining popliteal nodes, but the distribution of GFP is still quite broad and largely overlaps with that of cells from untreated SKG mice. The Nur77-eGFP expression in CD4 T cells isolated from the arthritic joints of SKG mice, however, is substantially increased but still overlaps with the expression distribution in CD4 T cells from untreated mice (Fig. 1A, gating in Fig. S1D ). This suggests that the T cell repertoire prior to and after zymosan stimulation has a broad distribution but the arthritogenic potential may not be limited to a narrow spectrum of autoreactive cells. This could account for the failure to date to identify a unique, dominant arthritogenic TCR in this model (29) . We took advantage of SKGNur mice to study this further.
We first used the Nur77-eGFP reporter to assess differences in TCR signaling between WT and SKG T cells during T cell development, as it seemed likely that a more autoreactive repertoire was being positively selected by self pMHC in SKG mice. The surface marker CD5 is dependent upon p56 lck activity throughout T cell development and is frequently used as an indicator of TCR signaling strength during and after thymic development (31) . We assessed both CD5 and Nur77-eGFP expression at sequential stages of T cell development in WTNur and SKGNur mice. Consistent with impaired TCR signaling in SKG mice as identified in previous studies, pre-selection double-positive (DP) thymocytes from SKGNur mice exhibited lower levels of both GFP and CD5 relative to those of WTNur (Fig. 1B left panel) . Prior work has identified a minimal threshold of TCR signaling that is necessary for positive selection (32) .
Consistent with this, after the positive selection checkpoint, GFP and CD5 were markedly upregulated in post-selection thymocytes in both WTNur and SKGNur mice. Of note, GFP expression levels in SKGNur CD4SP thymocytes became equivalent to WTNur, whereas CD5 expression remained subtly reduced in SKGNur CD4SP thymocytes (Fig. 1B) . Since TCR signaling is markedly dampened in SKG mice, high GFP expression in SKGNur CD4SP
thymocytes implies selection of a highly autoreactive repertoire where strong stimulation by selfpeptide MHC (self-pMHC) complexes compensates for impaired signal transduction in order to support positive selection (32) .
Surprisingly, we found that peripheral naïve and memory CD4 lymphocytes from SKGNur mice had somewhat higher GFP levels than WTNur controls (Fig. 1B , two right-hand panels). Note that Tregs, which are selected on the basis of self-reactivity during development and consequently express high levels of Nur77 (23) , were excluded in this analysis. This suggested to us that autoreactive SKG T cells were either exposed to chronic auto-antigen stimulation in the periphery or underwent further repertoire pruning under the influence of autoantigens and weak TCR signaling, or both. In contrast, CD5 surface expression was lower in SKGNur peripheral CD4 T cells compared to controls (Fig. 1B) . It is unclear why CD5 and Nur77 expression levels were discordant following positive selection and in the periphery.
However, CD5 is frequently used as a marker of proximal TCR signaling strength involving interactions with Lck and Cbl with the CD5 cytoplasmic tail, (9, 33, 34) . In contrast, Nur77 is reflective of transcriptional activation which is regulated by tonic and integrated downstream TCR signaling pathways (35) . Thus, we used Nur77-eGFP as a marker of TCR signaling strength in SKG peripheral T cells as it appeared to be a reliable marker of, not only strength of transduced TCR signal, but integrated TCR signaling reflective of antigen encounter in vivo over time.
Nur77-eGFP high expressing SKGNur CD4 T cells demonstrate increased autoreactivity
In view of the discordant expression of Nur77-eGFP and CD5 in peripheral CD4 T cells from SKGNur mice and the broad distribution of Nur77-eGFP expression, we sought to take an independent approach to probe the putative self-reactivity of the mature repertoire and whether Nur77-eGFP expression marked differences in the self-reactivity of this repertoire. We (Fig. 2D, Fig. S2D ). This increase in IL-17 producing cells was not observed in the CD4 T cells recovered from SCID mice that received WTNur GFP hi or GFP lo CD4 T cells. Collectively, our results suggest that the arthritogenic capacity of SKG CD4 T cells can be distinguished by their relative expression of Nur77-eGFP before disease onset, and corresponds to increased autoreactivity and proclivity to differentiate into pathogenic IL-17-secreting effectors in vitro and in vivo.
Autoreactive Nur77-eGFP hi SKG T cells signal poorly in response to TCR stimulation
We next sought to understand why arthritogenic GFP hi SKG T cells preferentially differentiated into Th17 effectors. Since GFP levels reflect integrated TCR signaling, we hypothesized that differences in TCR signaling by this population of T cells may contribute to their Nur77-GFP amounts (Fig. 3A) . We already showed that GFP hi SKG T cells are more selfreactive and therefore encounter more antigen in vivo ( Fig. 1C-D (Fig. 3B, Fig. S1 ). The calcium responses of GFP hi SKGNur CD4 T cell responses were even more dampened than those of GFP lo CD4 T cells (Fig. 3A) . Interestingly, an analogous trend was seen with GFP hi WTNur CD4 T cells relative to GFP lo WTNur CD4 T cells, suggesting that increased integrated TCR signaling input is associated with dampened downstream TCR signal transduction.
Analysis of TCR-induced Erk phosphorylation in purified peripheral CD4 T cells similarly
revealed that both GFP hi and GFP lo CD4 + CD25 -SKGNur T cells had a severe impairment in Erk phosphorylation after polyclonal TCR stimulation. This was observed in both the memory and naïve peripheral CD4 T cell compartments (Fig. 3C, Fig. S1 ). By contrast, responses to PMA which bypasses TCR signaling to Erk activation were normal, consistent with the well-defined role of Zap70 in regulating only proximal TCR signal transduction. In WTNur mice, GFP hi CD4 T cells appeared to have subtly decreased signaling capacity compared to GFP lo T cells, but the responses were still largely preserved, contrasting with the markedly impaired SKG responses (Fig. 3C) (Fig. 3E) . Moreover, SKGNur CD4
T cells exhibited a clear proliferative defect in response to platebound aCD3 stimulation as previously described (30) , which stands in marked contrast to SKGNur GFP hi naïve CD4 T cells' ability to proliferate in response to self-antigen ( Fig. 1D-E) . Therefore, these results indicate that differences in GFP expression between the most and least arthritogenic SKGNur CD4 T cells is not attributable to signal transduction machinery, but rather reflects TCR autoreactivity to selfpMHC (antigen recognition). It is possible that downmodulation of TCR signal strength in GFP hi relative to GFP lo CD4 T cells could represent a compensatory peripheral tolerance mechanism to prevent inappropriate activation of self-reactive clones. Collectively, these results suggest that differences in the measured TCR signal transduction events do not account for unique propensity of GFP hi CD4 T cells from SKGNur mice to differentiate in vivo and in vitro into Th17 effectors.
Upregulation of several inhibitory receptors in SKG GFP hi cells
It was quite surprising that GFP hi CD4 T cells from SKGNur mice were able to exert their effector functions leading to joint immunopathology despite their profound impairment to in vitro TCR signal transduction (Fig. 3) . To account for the discrepancy between arthritogenic and signaling potential of the GFP hi cells as detected here, we next asked whether GFP hi CD4 T cells from SKGNur mice expressed much lower levels of inhibitory receptors, thereby permitting them to expand more rapidly in a lymphopenic environment, or whether they expressed higher levels of inhibitory receptors, further compromising their impaired TCR signaling capacity compared to GFP lo CD4 T cells. To address this, we examined the surface expression of several inhibitory receptors (PD-1, TIGIT, CD73) which have been shown to dampen downstream TCR signaling, the latter of which marks 'anergic' T cell populations (39). GFP hi CD4 T cells expressed higher levels of these inhibitory receptors than their GFP lo counter parts, again suggesting that this may represent a compensatory tolerance mechanism to constrain self-reactive T cells (Fig. 4) . However, higher expression levels of inhibitory receptors observed in the GFP hi population were not unique to SKGNur T cells since WTNur GFP hi CD4 T cells also upregulated inhibitory receptors compared to WTNur GFP lo CD4 T cells. This is in line with a recent report demonstrating that NR4A gene expression positively correlated with PDCD1 (PD-1), TIGIT, and other inhibitory receptors in the setting of chronic antigen stimulation as part of a T cell-intrinsic program of hyporesponsiveness (40). This may in part account for the relative hyporesponsiveness we observed in GFP hi T cells (Fig. 3) . Therefore it is all the more striking that SKGNur GFP hi CD4 T cells upregulate inhibitory pathway receptors and yet, despite this, exhibit the capability to proliferate in response to autologous APCs, differentiate into IL-17
producing cells, and cause more severe arthritis.
Enhanced IL-6 response in GFP hi CD4 T cells from SKGNur mice
Th17 differentiation depends not only on TCR signaling in response to pMHC, but also upon polarizing cytokines. Given the critical role of IL-6 in the development of arthritogenic Th17 cells in SKG mice (36) , the differential responsiveness to IL-6 signaling might, at least in part, account for differences in the arthritogenic and effector potential of GFP hi and GFP lo SKGNur CD4 T cells. We examined in vitro responsiveness of SKG and WT CD4 T cells to IL-6.
Phospho-flow cytometric analyses revealed that SKGNur GFP hi CD4 T cells have higher basal levels of phosphorylated-STAT3 than GFP lo CD4 T cells (Fig. 5A-B) . This difference was not observed amongst comparable populations from unstimulated WTNur CD4 T cells. Interestingly, inducible STAT3 phosphorylation in response to IL-6 stimulation in the GFP hi populations was more robust than that of the GFP lo populations but this was observed in both SKGNur and WTNur mice. The overall response to IL-6 stimulation in both the SKGNur GFP hi and GFP lo CD4
T cells was much greater than in the comparable populations obtained from WTNur CD4 T cells ( Fig. 5A-B) . To investigate whether IL-6 hyper-responsiveness in SKG mice was due to differences in total STAT3 protein expression levels, we first compared the expression levels of STAT3 between WT and SKG mice. As shown in Fig. 5C , we found that STAT3 expression was comparable between WT and SKG CD4 T cells.
We next sought to examine the IL-6 pathway in greater detail (Fig. 5D) . We first analyzed the expression of both components of the IL-6 receptor, the ligand-binding IL-6Ra
chain CD126 and the IL-6 family common receptor subunit gp130 (CD130) which is essential for signal transduction following cytokine engagement (41). As shown in Fig. 5E -F, the GFP hi populations expressed significantly higher amounts of CD130 than did the GFP lo populations.
However, there was no significant difference in CD130 expression between WTNur and SKGNur mice. We did observe minimal differential expression of CD126 protein between the GFP hi and GFP lo populations (Fig. 5E-F) , although the impact of the very small differences is not clear. These results indicate that the GFP hi and GFP lo populations differ in their expression of CD130, perhaps contributing to relatively increased IL-6 responses by GFP hi T cells.
Since the differences in the receptor subunits did not seem to account for the greater IL-6 response in SKGNur mice compared to WTNur controls, we further assessed key signaling molecules downstream of the IL-6 signaling pathway such as JAK1, JAK2, and SOCS3. Similar to surface expression of CD130, GFP hi CD4 T cells expressed higher amounts of JAK1 and JAK2 mRNA than did GFP lo CD4 T cells (Fig. 5G) . Nevertheless, the expression levels of JAK1
and JAK2 transcripts were comparable between the respective CD4 T cell populations isolated from GFP populations in WTNur and SKGNur mice (Fig. 5G) . Thus, increased expression of CD130, JAK1 and JAK2 in GFP hi CD4 T cells might contribute to enhanced IL-6 response in this population, but both WTNur and SKGNur shared these properties. Immunoblot analyses indicated that SOCS3 protein, a key negative regulator of IL-6 signaling (42), was downregulated in SKGNur CD4 T cells (Fig. 5H-I) . Our results suggest that the hyperresponsiveness to IL-6 observed in autoreactive SKGNur CD4 T cells exposed to chronic antigen stimulation may be due at least in part to decreased SOCS3-dependent suppression.
We propose that SKGNur GFP hi CD4 T cells exhibit uniquely robust IL-6 responses because they both upregulate the IL-6 proximal signaling machinery and coordinately express lower levels of the negative regulator SOCS3. Other regulators of this pathway could also influence the differential IL-6R responses of T cells from the WT vs SKG genotypes.
Nur77 identifies increased frequencies of antigen-stimulated CD4 T cells in arthritic SKG synovium.
A central challenge in isolating bona-fide antigen-activated T cells from inflamed arthritic joints from patients with rheumatoid arthritis is differentiating these from T cells activated via cytokines in the inflammatory milieu (43). Recently, we developed technologies to detect induction of endogenous Nur77 protein following TCR and BCR stimulation in mouse and human T cells. Since Nur77 is induced downstream of TCR but not cytokine receptor signaling ( Fig. 6A) (21, 23, 24) , and we observed increased expression of Nur77-eGFP in arthritic joints of SKG mice (Fig. 1A) , we determined whether endogenous Nur77 protein was also upregulated in T cells after arthritis induction by zymosan challenge in SKG mice. Indeed, when examining the CD4 T cell population infiltrating arthritic SKG joints after zymosan treatment, we found upregulation of endogenous Nur77 protein in a subset of CD4 T cells from SKG arthritic joints compared to non-arthritic PBS treated SKG mice (Fig. 6B, gating in Fig. S1D ).
Consistent with intracellular Nur77 expression, Nur77 transcript levels (Nr4a1) were increased approximately 6-fold in the population of joint infiltrating CD4 T cells from zymosan-treated SKG mice (Fig. 6C) .
The discrepancy between greater percentage of CD4 T cells expressing high GFP amounts (Fig. 1A) compared to endogenous Nur77 may be due to the long in vivo half-life of GFP in comparison to endogenous Nur77 (22) , but does also suggest a high degree of heterogeneity in the autoreactivity of the CD4 T cell population within the arthritic joint.
Together, these data show that zymosan challenge in SKG(Nur) mice, which triggers activation of autoreactive CD4 T cells, led to upregulation of a population of cells that expressed higher levels of endogenous Nur77 expression in the inflamed joints. Since Nur77 marks antigendependent TCR signaling specifically, and the half-life of endogenous Nur77 is short (44), these results suggest that the joint-infiltrating CD4 T cells in SKG mice are recognizing an intraarticular antigen(s).
Nur77 protein, a specific indicator of TCR signaling, identifies increased frequencies of antigenstimulated CD4 T cells in human RA synovium.
Utilizing methodology we optimized for intracellular Nur77 staining in human
lymphocytes (21), we used endogenous Nur77 protein expression to determine whether jointinfiltrating CD4 T cells in human RA patients might be recognizing an intra-articular antigen, and as proof-of-concept to establish whether this marker could in turn be subsequently used to identify arthritogenic TCR specificities in RA patients. We analyzed Nur77 expression in synovial T cells from eight patients undergoing a surgical joint procedure that met the American College of Rheumatology classification criteria for seropositive (rheumatoid factor or anti-CCP antibody positive) RA (Table S1 ). We found a significant increase in a fraction of Nur77-positive CD4 T cells isolated from synovial tissue from patients with seropositive RA compared to matched PBMCs from the same donor ( Fig. 6D and 6E , human gating in Fig. S3A ), suggesting an enrichment of antigen-reactive cells in the joint. The expression of Nur77 protein in CD4 T cells obtained from the joints of RA patients far exceeded those isolated from synovial tissue of patients with a diagnosis of osteoarthritis (OA), a non-autoimmune degenerative form of arthritis (Fig. 6D, 6F, Fig. S3A) . Importantly, the enrichment of endogenous Nur77 was only observed in synovial infiltrating CD4 T cells and not in CD8 T cells in RA synovium (Fig. 6D) We then searched general public repository databases for available transcriptome data from RA synovial tissue. Thirteen studies met our inclusion criteria comprising over 300 synovial samples (Table S2) . Leveraging all collected publicly available microarray data we specifically looked into the SOCS3 gene. We found that SOCS3 was down-regulated in RA synovial tissue compared to controls with the fold change 0.65 and p-value 5E-10 ( Fig. 7A-B) . Distribution plots per individual study are shown in Fig. S4 . Furthermore, we interrogated the expression of additional IL-6 signaling pathway components and found minimal to no differences between patients with RA and controls, apart from JAK2 ( Fig. 7B-C) . These results suggest a mechanism whereby IL-6 signaling may go unchecked and contribute to persistent inflammatory responses in the RA joint.
Discussion
Here we describe an innovative approach, through the detection and monitoring of Our future studies will further characterize the synovial CD4 T cell subsets that express high levels of Nur77 (NR4A1) using single cell RNA sequencing. For clinical investigators, these results highlight the importance of studying the relevant tissues, rather than blood samples, to elucidate antigen-driven events in relevant target tissues. Monocytes were isolated by density gradient Ficoll separation as previously described (21) . Intracellular staining. For Nur77 staining in murine and human cells, assays were performed as previously described (21) . For intracellular cytokine staining, LN or spleen cells were stimulated with 50 ng/ml PMA and 1 μM ionomycin in the presence of Golgi-Stop (BD Biosciences) for 5 h, and then stained with anti-CD4 and anti-TCR-β and fixed and permeabilized using BD Cytofix/Cytoperm (BD Biosciences), followed by anti-IL-17 staining.
Phospho-Erk and phospho-S6 assays: negatively selected peripheral T cells were rested in serum-free medium for 2 h at 37°C, after which they were stimulated with 5 µg/ml of anti-CD3
(clone 2C11), followed by the addition of 50 µg/ml goat anti-Armenian hamster IgG (Jackson Immunoblot analysis. SKG and WT total CD4 cells were purified from single cell suspensions of spleen and lymph nodes by negative selection with biotinylated antibodies and magnetic beads as previously described (82) . Cells were lysed by directly adding 10 % NP-40 lysis buffer to the final concentration of 1% NP40 (containing inhibitors of 2 mM NaVO4, 10 mM NaF, 5 mM EDTA, 2 mM PMSF, 10 μg/ml Aprotinin, 1 μg/ml Pepstatin and 1 μg/ml Leupeptin). Lysates were placed on ice and centrifuged at 13,000 g to pellet cell debris. Supernatants were run on 10% Bis-Tris Protein Gels (ThermoFisher Scientific) and transferred to PVDF membranes using a Trans-Blot Turb Transfer System (Bio Rad). Membranes were blocked using TBS-T buffer containing 3% BSA, and probed with primary antibodies as described, overnight at 4 °C or 2 h at room temperature. The following day, blots were rinsed and incubated with HRP-conjugated secondary antibodies. Blots were detected using a chemiluminescent substrate and a BioRad Chemi-Doc imaging system.
Statistics.
Results from independent experiments were pooled whenever possible, and all data were analyzed using Prism version 5.0f for Mac (GraphPad Software, La Jolla, California). All data were analyzed by comparison of means using paired or unpaired two-tailed Student's t tests. Data in all Fig.s represent mean ± S.E.M. unless otherwise indicated. Differences were considered significant at P < 0.05.
Genomic data collection and preprocessing.
A comprehensive search for publicly available microarray data at NCBI Gene Expression Omnibus (83) (GEO) database (http://www.ncbi.nlm.nih.gov/geo/) was performed. The keywords "rheumatoid arthritis", "synovium", "synovial", and "biopsy", among organism "Homo Sapiens" and study type "Expression profiling by array" were used. The criteria for the dataset exclusion from the search results were the lack of annotations and low probe platforms. We were able to collect 13 datasets with 312 synovial biopsies ( Table S2) The raw data in the .cel, .txt, and .gpr file formats were downloaded and pre-processing steps were performed using R language (84) version 3.4.4 and the Bioconductor (85) packages affy (86) and limma (87) . They included background correction, log2-transformation, and intrastudy quantile normalization. Finally, we performed probe-gene mapping, data merging and cross-study normalization using the ComBat (88) method in R package sva (89) in order to minimize the batch effect contribution to the analysis results. After the merge the total number of common genes was 7,078 since some studies were performed on older platforms with lower number of probes. We specifically queried this data for the expression of the SOCS3 gene. The study GSE3698 did not contain additional genes queried in the IL-6 pathway, therefore this study was removed for analysis of IL6ST, IL6R, JAK1, JAK2, STAT3.
Code availability: the code is available upon request.
Data availability: The data is available in NCBI GEO repository under assertion numbers GSE12021, GSE21537, GSE24742, GSE36700, GSE3698, GSE39340, GSE45867, GSE48780, GSE55235, GSE55457, GSE55584, GSE57376, GSE77298. (B) Quantification of % positive inhibitory receptor levels. Box plots describe the median and inter-quartile range (IQR), whiskers extend to the largest value, but no further than 1.5*IQR, data points beyond whiskers are outlying points.
ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, by two-tailed Student's t test. Quantification of SOCS3 protein levels normalized to b-actin pooled from three immunoblot experiments as shown in (H) with 11-12 mice in each group. Ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, by two-tailed Student's t test. 
